- Home
- RMTI vs VERU Comparison
RMTI vs VERU Comparison
Compare RMTI & VERU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- VERU
- Stock Information
- Founded
- RMTI 1994
- VERU 1971
- Country
- RMTI United States
- VERU United States
- Employees
- RMTI N/A
- VERU N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- VERU Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- VERU Health Care
- Exchange
- RMTI Nasdaq
- VERU Nasdaq
- Market Cap
- RMTI 72.7M
- VERU 107.2M
- IPO Year
- RMTI 1998
- VERU 1990
- Fundamental
- Price
- RMTI $2.25
- VERU $0.68
- Analyst Decision
- RMTI Strong Buy
- VERU Strong Buy
- Analyst Count
- RMTI 2
- VERU 4
- Target Price
- RMTI $7.00
- VERU $4.00
- AVG Volume (30 Days)
- RMTI 1.2M
- VERU 922.2K
- Earning Date
- RMTI 11-12-2024
- VERU 12-06-2024
- Dividend Yield
- RMTI N/A
- VERU N/A
- EPS Growth
- RMTI N/A
- VERU N/A
- EPS
- RMTI N/A
- VERU N/A
- Revenue
- RMTI $98,917,000.00
- VERU $14,091,909.00
- Revenue This Year
- RMTI $22.20
- VERU N/A
- Revenue Next Year
- RMTI $8.76
- VERU N/A
- P/E Ratio
- RMTI N/A
- VERU N/A
- Revenue Growth
- RMTI 22.37
- VERU N/A
- 52 Week Low
- RMTI $1.16
- VERU $0.36
- 52 Week High
- RMTI $5.15
- VERU $1.92
- Technical
- Relative Strength Index (RSI)
- RMTI 31.71
- VERU 43.72
- Support Level
- RMTI $2.15
- VERU $0.57
- Resistance Level
- RMTI $2.59
- VERU $0.83
- Average True Range (ATR)
- RMTI 0.33
- VERU 0.05
- MACD
- RMTI -0.16
- VERU -0.00
- Stochastic Oscillator
- RMTI 3.33
- VERU 40.38
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.